Jun 2026 (Q2 FY26) — Aug 5, 2026
Carlsmed Q2 FY26 — Strong Revenue Growth and Strategic Product Launches
Read the full callCarlsmed (CARL) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Carlsmed earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 18.9 | +56.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -58.3 | −4.5 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -10.5 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$13.66 +1.86% · +$0.25
Performance +0.8% 1Y
1Y: $13.55 on 17 Oct 2025 → $13.66. High $16.99 (3 Dec 2025), low $8.83 (29 Apr 2026).
- Previous close
- $13.41
- 52-week range
- $8.83 – $16.99
- One year
- −5.07%
Overview
- Symbol
- CARL
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Carlsmed earnings calls (CARL)
Financials
What the filings say
Net profit, year on year: −55% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 7 | 9 | 10 | 12 | 13 | 15 | 16 | 19 |
| Operating profit | -8 | -5 | -6 | -7 | -9 | -9 | -9 | -11 |
| Operating margin | −118.0% | −49.9% | −56.1% | −53.8% | −69.1% | −61.4% | −57.6% | −58.3% |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | -8 | -5 | -6 | -7 | -9 | -9 | -9 | -11 |
| EPS ($ per share) | -2.06 | — | -1.47 | -1.47 | -0.40 | — | -0.32 | -0.39 |
| Line item | Dec 2024 | Dec 2025 |
|---|---|---|
| Equity capital | 0 | 0 |
| Reserves | -71 | -101 |
| Total liabilities | 26 | 31 |
| Fixed assets | 0 | 1 |
| Investments | 0 | 24 |
| Total assets | 52 | 130 |
| Line item | Dec 2024 | Dec 2025 |
|---|---|---|
| Cash from operations | -25 | -29 |
| Cash from investing | -0 | -25 |
| Cash from financing | 58 | 100 |
| Capital expenditure | -0 | -1 |
| Free cash flow | -26 | -30 |
Insider filings
17 filings between Jan 28, 2026 and Oct 5, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$2.64M
3 sales by 2 insiders
67% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 9
- Award — granted as compensation
- 5
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Cordonnier Michael | — | $2.63M | Mar 2, 2026 |
| Bertolini Jeffrey | — | $14.1K | Oct 5, 2026 |
Latest filings (45)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Bertolini Jeffrey Chief Operating Officer | Option exercise 10b5-1 plan | 747 | $4.4K |
| Oct 5, 2026 | Bertolini Jeffrey Chief Operating Officer | Sale 10b5-1 plan | 747 | $10.7K |
| Sep 30, 2026 | Bertolini Jeffrey Chief Operating Officer | Option exercise 10b5-1 plan | 243 | $542 |
| Sep 30, 2026 | Bertolini Jeffrey Chief Operating Officer | Sale 10b5-1 plan | 243 | $3.4K |
| Sep 28, 2026 | Heppenstall Richard CFO, Treasurer | Award | 89,286 | $0 |
| Jun 3, 2026 | YOUNG PHILIP M Director | Award | 13,698 | $0 |
| Jun 3, 2026 | ROOT JONATHAN D Director | Award | 13,698 | $0 |
| Jun 3, 2026 | Sidow Kevin Director | Award | 13,698 | $0 |
| Jun 3, 2026 | OBOYLE KEVIN C Director | Award | 13,698 | $0 |
| Mar 3, 2026 | Cordonnier Michael CEO, President | Option exercise | 33,264 | $144.8K |
| Mar 3, 2026 | Cordonnier Michael CEO, President | Option exercise | 160,567 | $53.8K |
| Mar 2, 2026 | Cordonnier Michael CEO, President | Option exercise | 197,855 | $66.3K |
| Mar 2, 2026 | Cordonnier Michael CEO, President | Sale | 197,855 | $2.63M |
| Jan 28, 2026 | Durall William Scott Chief Commercial Officer | Award | 44,977 | $0 |
| Jan 28, 2026 | Casey Niall Chief IP Officer | Award | 44,977 | $0 |
| Jan 28, 2026 | Cordonnier Michael CEO, President | Award | 117,316 | $0 |
| Jan 28, 2026 | Greenstein Leonard M. CFO, Treasurer | Award | 44,977 | $0 |
| Jul 24, 2025 | Presidio Management Group XII, L.L.C. 10% owner | Purchase | 200,000 | $3.00M |
| Jul 24, 2025 | YOUNG PHILIP M Director | Purchase | 53,333 | $800.0K |
| Jul 24, 2025 | YOUNG PHILIP M Director | Purchase | 6,666 | $100.0K |
| Jul 24, 2025 | YOUNG PHILIP M Director | Conversion | 28,900 | — |
| Jul 24, 2025 | ROOT JONATHAN D Director | Conversion | 825,135 | — |
| Jul 24, 2025 | ROOT JONATHAN D Director | Conversion | 26,993 | — |
| Jul 24, 2025 | ROOT JONATHAN D Director | Conversion | 1,117,743 | — |
| Jul 24, 2025 | ROOT JONATHAN D Director | Purchase | 466,666 | $7.00M |
| Jul 24, 2025 | Casey Niall Chief IP Officer, Secretary | Option exercise | 3,612 | — |
| Jul 24, 2025 | ROOT JONATHAN D Director | Conversion | 531,877 | — |
| Jul 24, 2025 | Mittendorff Robert II Director | Conversion | 3,680,506 | — |
| Jul 24, 2025 | Mittendorff Robert II Director | Purchase | 1,333,333 | $20.00M |
| Jul 24, 2025 | Mittendorff Robert II Director | Conversion | 2,376,472 | — |
| Jul 24, 2025 | Mittendorff Robert II Director | Conversion | 931,452 | — |
| Jul 24, 2025 | ROOT JONATHAN D Director | Conversion | 149,655 | — |
| Jul 24, 2025 | Sidow Kevin Director | Option exercise | 28,900 | — |
| Jul 24, 2025 | Sidow Kevin Director | Purchase | 13,333 | $200.0K |
| Jul 24, 2025 | Cordonnier Michael CEO, President | Option exercise | 3,612 | — |
| Jul 24, 2025 | B CAPITAL GROUP MANAGEMENT, L.P. 10% owner | Conversion | 3,680,506 | — |
| Jul 24, 2025 | B CAPITAL GROUP MANAGEMENT, L.P. 10% owner | Purchase | 1,333,333 | $20.00M |
| Jul 24, 2025 | B CAPITAL GROUP MANAGEMENT, L.P. 10% owner | Conversion | 2,376,472 | — |
| Jul 24, 2025 | B CAPITAL GROUP MANAGEMENT, L.P. 10% owner | Conversion | 931,452 | — |
| Jul 24, 2025 | ROOT JONATHAN D Director | Conversion | 2,948,794 | — |
| Jul 24, 2025 | ROOT JONATHAN D Director | Conversion | 41,876 | — |
| Jul 22, 2025 | YOUNG PHILIP M Director | Award | 17,333 | $0 |
| Jul 22, 2025 | OBOYLE KEVIN C Director | Award | 17,333 | $0 |
| Jul 22, 2025 | Sidow Kevin Director | Award | 17,333 | $0 |
| Jul 22, 2025 | ROOT JONATHAN D Director | Award | 17,333 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for CARLSMED, INC.
Free account. Everything above stays public.
Write why you follow CARLSMED, INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading